Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Sep
14
2016
Triclosan is Not GRAS/GRAE in OTC Antiseptic Products, Says FDA Keller and Heckman LLP
Sep
13
2016
USDA Issues RFI to Support Development of New GMO Labeling Law Keller and Heckman LLP
Sep
12
2016
EPA Requests Six Month Extension of Deadline for Decision on Chlorpyrifos Tolerance Revocation Bergeson & Campbell, P.C.
Sep
12
2016
Bus Mechanic Who Uses Adderall for ADHD Can Proceed with Disability Discrimination Claims Jackson Lewis P.C.
Sep
12
2016
California's Proposition 65: All Eyes on Aspartame Keller and Heckman LLP
Sep
12
2016
New Alcohol and Tobacco Tax and Trade Bureau Final Rule Released on Denatured Alcohol McDermott Will & Emery
Sep
10
2016
EPA Issues FIFRA SAP Minutes on EPA Proposal to Use Biomonitoring Data to Derive a PoD for Chlorpyrifos Bergeson & Campbell, P.C.
Sep
10
2016
Ninth Circuit Denies EPA’s Request for Six-Month Extension on Chlorpyrifos Decision; Grants Three-Month Extension Bergeson & Campbell, P.C.
Sep
9
2016
Perdue v. Wyeth Pharmaceuticals, Inc.: A Triple Knockout on Pre-Emption and Innovator Liability Grounds Sills Cummis & Gross P.C.
Sep
9
2016
No Changes for Ohio Employers under the State’s New Medical Marijuana Law Squire Patton Boggs (US) LLP
Sep
9
2016
FDA Draft Guidance: Substantiation for Infant Formula Structure/Function Claims Keller and Heckman LLP
Sep
9
2016
Florida House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology Bergeson & Campbell, P.C.
Sep
9
2016
Synopsis Available for 2016 U.S.-EU: Bridging NanoEHS Research Efforts Joint Workshop Bergeson & Campbell, P.C.
Sep
9
2016
Shipments from Florida to China Must Undergo Mosquito Disinsection Keller and Heckman LLP
Sep
9
2016
Buyer Beware—That Mosquito Repellent May Not Have Been Tested For Efficacy Bergeson & Campbell, P.C.
Sep
9
2016
EPA Issues Guidance for Antimicrobial Pesticide Products to Combat Emerging Viral Pathogens Bergeson & Campbell, P.C.
Sep
8
2016
FDA Requests Comments on Regulatory Status of Vinpocetine Keller and Heckman LLP
Sep
7
2016
The EpiPen Controversy Signals Intensifying Scrutiny of Drug Classification Under Medicaid Rebate Program Foley & Lardner LLP
Sep
7
2016
Lawsuit Challenges “Pasture Raised” Claims: Bucolic Brouhaha Keller and Heckman LLP
Sep
7
2016
Promoting Off-Label Use: Are Times Changing at FDA? Dinsmore & Shohl LLP
Sep
6
2016
New FDA Regulations for OTC Antibacterial Hand and Body Washes Katten
Sep
6
2016
District of Massachusetts Court Extends Myriad to Peptide Panels Schwegman, Lundberg & Woessner, P.A.
Sep
6
2016
United States v. Caira: Reasonable Expectations of (Data) Privacy in Digital World? Faegre Drinker
Sep
6
2016
FDA Warns Against Mixing Opioid Medications and Benzodiazepines Jackson Lewis P.C.
Sep
6
2016
DEA Intends to Classify Kratom as Schedule I Drug Jackson Lewis P.C.
Sep
6
2016
Prop 65: CA Adopts New “Clear and Reasonable Warning” Requirements Keller and Heckman LLP
Sep
6
2016
Anti-Aging Advertising Claims Unsubstantiated by Testing Methods: Wrinkle in Time Proskauer Rose LLP
Sep
6
2016
President Obama Signs GMO Labeling Bill into Law Greenberg Traurig, LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins